on Medication Treatment of Childhood Major Depressive Disorder

Objectives: To develop consensus guidelines for medication treatment algorithms for childhood major depressive disorder (MDD) based on scientific evidence and clinical opinion when science is lacking.The ultimate goal of this approach is to synthesize research and clinical experience for the practitioner and to increase the uniformity of preferred treatment for childhood MDD. A final goal is to develop an approach that can be tested as to whether it improves clinical outcomes for children and adolescents with MDD. Method: A consensus conference was held. Participants included academic clinicians and researchers, practicing clinicians, administrators, consumers, and families.The focus was to review and use clinical evidence to recommend specific pharmacological approaches for treatment of MDD in children and adolescents. After a series of presentations of current research evidence and panel discussion, the consensus panel met, agreed on assumptions, and drafted the algorithms. The process initially addressed strategies of treatment and then tactics to implement the strategies. Results: Consensually agreed-upon algorithms for major depressions (with and without psychosis) and comorbid attention deficit disorders were developed. Treatment strategies emphasized the use of selective serotonin reuptake inhibitors. The algorithm consists of systematic strategies for treatment interventions and recommended tactics for implementation of the strategies, including medication augmentation and medication combinations. Participants recommended prospective evaluation of the algorithms in various public sector settings, and many volunteered as sites for such an evaluation. Conclusions: Using scientific and clinical experience, consensus-derived algorithms for children and adolescents with MDD can be developed. J. Am. Acad. Child Adolesc. Psychiatq 1999, 38(11):1442-1454. Key Words: medication algorithm, childhood disorders, major depressive disorder, medication consensus conference, childhood psychopharmacology, child and adolescent depression.

[1]  J. Swanson,et al.  The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[2]  J. Biederman,et al.  Multicenter open-label sertraline study in adolescent outpatients with major depression. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  J. Walkup,et al.  Nontricyclic antidepressants: current trends in children and adolescents. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  C. Pataki,et al.  The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls. , 1999, The Journal of clinical psychiatry.

[5]  Alexander L. Miller,et al.  Implementing guidelines and systems of care: Experiences with the Texas Medication Algorithm Project (TMAP) , 1999 .

[6]  A. Rush,et al.  Consensus guidelines in the treatment of major depressive disorder. , 1998, The Journal of clinical psychiatry.

[7]  M. Crismon,et al.  Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms. , 1998, The Journal of clinical psychiatry.

[8]  C. Pataki,et al.  Complete remission of 'treatment resistant' severe melancholia in adolescents with phenelzine: two case reports. , 1998, Journal of affective disorders.

[9]  S. Preskorn,et al.  Serotonin Syndrome Induced by Venlafaxine and Fluoxetine: A Case Study in Polypharmacy and Potential Pharmacodynamic and Pharmacokinetic Mechanisms , 1998, The Annals of pharmacotherapy.

[10]  M. State,et al.  Effects of Electroconvulsive Therapy in Adolescents with Severe Endogenous Depression Resistant to Pharmacotherapy , 1998, Biological Psychiatry.

[11]  A. Rush,et al.  A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. , 1997, Archives of general psychiatry.

[12]  F. Benazzi.  Severe Anticholinergic Side Effects with Venlafaxine—Fluoxetine Combination , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[13]  S Iyengar,et al.  A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. , 1997, Archives of general psychiatry.

[14]  C. Gillberg,et al.  Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. , 1997, Archives of general psychiatry.

[15]  R. Dahl,et al.  Childhood and adolescent depression: a review of the past 10 years. Part I. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[16]  J. Swanson,et al.  Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  H. Sackeim,et al.  Resistance to antidepressant medications and short-term clinical response to ECT. , 1996, The American journal of psychiatry.

[18]  R. Balon,et al.  Augmentation with buspirone: a review. , 1995, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[19]  M. Fink.  Electroconvulsive Therapy, 2nd ed , 1993 .

[20]  J. Biederman,et al.  Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  T. Crow,et al.  Who Benefits from Electroconvulsive Therapy? , 1992, British Journal of Psychiatry.

[22]  M. Bertagnoli,et al.  A review of ECT for children and adolescents. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[23]  N. Ryan,et al.  MAOIs in adolescent major depression unresponsive to tricyclic antidepressants. , 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

[24]  N. Ryan,et al.  Lithium antidepressant augmentation in TCA-refractory depression in adolescents. , 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

[25]  M. Trivedi,et al.  The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. , 1999, The Journal of clinical psychiatry.

[26]  C. Hammen,et al.  The context of depression in clinic-referred youth: neglected areas in treatment. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[27]  Philip D. Harvey,et al.  Predictors of medication compliance after hospital discharge in adolescent psychiatric patients. , 1998, Journal of child and adolescent psychopharmacology.

[28]  M. Strober.  Mixed mania associated with tricyclic antidepressant therapy in prepubertal delusional depression: three cases. , 1998, Journal of child and adolescent psychopharmacology.

[29]  J. Nelson.  Augmentation strategies for treatment of unipolar major depression. , 1997, Modern problems of pharmacopsychiatry.

[30]  A. Nierenberg,et al.  Algorithms for the treatment of subtypes of unipolar major depression. , 1995, Psychopharmacology bulletin.

[31]  S. Kutcher,et al.  Electroconvulsive Therapy in Treatment-Resistant Bipolar Youth , 1995 .

[32]  J. Biederman,et al.  A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. , 1995, The Journal of nervous and mental disease.

[33]  M. Riddle,et al.  Sertraline for Major Depression in Children and Adolescents: Preliminary Clinical Experience , 1995 .

[34]  Rush Aj,et al.  FROM SCIENTIFIC KNOWLEDGE TO THE CLINICAL PRACTICE OF PSYCHOPHARMACOLOGY :CAN THE GAP BE BRIDGED ? , 1995 .

[35]  M. Strober,et al.  The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[36]  Harrington Rc.  Adult outcomes of childhood and adolescent depression. , 1991 .